J&J booster slashes Omicron hospitalizations – South Africa study
A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing ...
Read moreA booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing ...
Read moreSouth Africa's health regulator on Thursday approved the use of Johnson & Johnson vaccine for a ...
Read moreJohnson & Johnson said on Thursday it had filed for an approval from European regulators for ...
Read more© 2021 FurtherMarkets
© 2021 FurtherMarkets